Search Login Register

Andersen Syndrome Summary

Description: A form of inherited long QT syndrome (or LQT7) that is characterized by a triad of potassium-sensitive periodic paralysis, VENTRICULAR ECTOPIC BEATS, and abnormal features such as short stature, low-set ears, and SCOLIOSIS. It results from mutations of KCNJ2 gene which encodes a channel protein (INWARD RECTIFIER POTASSIUM CHANNELS) that regulates resting membrane potential.

Also Known As: Long QT Syndrome 7; Syndrome, Andersen

Networked: 14 relevant articles (0 outcomes, 0 trials/studies) for this Disease

Key Drugs and Agents for Andersen Syndrome

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Inwardly Rectifying Potassium Channels (Inward Rectifier Potassium Channels) : 3 results : IBA
  2. Potassium : 2 results : IBA
  3. Andersen Tawil syndrome : 2 results : IBA
  4. Polymorphic catecholergic ventricular tachycardia : 2 results : IBA
  5. Kir2.1 channel : 2 results : IBA
  6. Potassium Channels (Potassium Channel) : 1 result : IBA
  7. Ion Channels (Ion Channel) : 1 result : IBA
  8. Flecainide (Tambocor) : 1 result : FDA 7 Generic
  9. Amiodarone (Amiodarona) : 1 result : FDA 4 Generic
  10. Acetazolamide (Diamox) : 1 result : FDA 13 Generic
Show All >>

Diseases Related to Andersen Syndrome

  1. Cardiac Arrhythmias (Arrythmia)
  2. Brugada Syndrome
  3. Paralysis (Palsy)
  4. Long QT Syndrome
  5. Jervell-Lange Nielsen Syndrome (Jervell and Lange-Nielsen Syndrome)
Show All >>

Key Therapies for Andersen Syndrome

Efficacy Chart >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.